The present invention discloses Atovaquone prodrugs, process for the preparation of said prodrugs and pharmaceutical compositions comprising Atovaquone prodrugs. Atovaquone prodrugs of the present invention can be used alone, or co-administered orally or parenterally as fixed dose or as separate dosage form in combinations with other anti-parasitic drugs for both prophylaxis and treatment of ecto and endo-parasitic infections in humans. The pharmaceutical compositions offer high drug loading due to higher solubility compared to Atovaquone and provides sustained depot effect, thus providing therapeutically effective concentration of active drug for longer duration.
[EN] METHOD FOR PRODUCING VERY-LONG-CHAIN POLYUNSATURATED FATTY ACID<br/>[FR] PROCÉDÉ DE FABRICATION D'ACIDE GRAS POLYINSATURÉ À CHAÎNE TRÈS LONGUE<br/>[JA] 超長鎖多価不飽和脂肪酸の製造方法